Johnson & Johnson vs Eli Lilly and at a glance
Both companies operate in the Health Care sector, so these figures are broadly like-for-like.
| Metric | JNJ | LLY |
|---|---|---|
| Market cap | $654.04B | $1.05T |
| Price | $268.04 | $1,174.61 |
| P/E ratio (TTM) | 18.74 | 46.69 |
| P/B ratio (MRQ) | 6.16 | 36.31 |
| P/S ratio (TTM) | 5.33 | 14.78 |
| Revenue growth (1Y) | 6.05% | 44.70% |
| Return on equity (TTM) | 32.87% | 77.78% |
| Return on invested capital (TTM) | 16.26% | 34.50% |
| Gross margin (TTM) | 75.17% | 84.01% |
| Net margin (TTM) | 21.48% | 33.53% |
| Dividend yield (TTM) | 2.00% | 0.59% |
How they differ
Eli Lilly and is the larger company at $1.05T versus $654.04B — about 1.6x the size.
On trailing earnings, Johnson & Johnson is the cheaper of the two at 18.74 against 46.69 for Eli Lilly and.
On sales, Johnson & Johnson is the cheaper of the two at 5.33 against 14.78 for Eli Lilly and.
Eli Lilly and leads on revenue growth over the past year, 44.70% against 6.05%.
Eli Lilly and leads on return on invested capital, 34.50% against 16.26%.
Eli Lilly and leads on gross margin, 84.01% against 75.17%.
Johnson & Johnson offers the higher yield at 2.00% against 0.59%.
Go deeper
Ratios describe the past. Whether either is worth owning depends on what you pay today.
Related comparisons
Other matchups involving Johnson & Johnson or Eli Lilly and.